GHK-Cu: research reference

A combination needs its own evidence for a claim about that combination. Component references must remain identified as component evidence.

In in vitro studies, the complex modulates expression of genes associated with the extracellular matrix in cultured fibroblasts. In cellular models, its activity has been linked to copper ion coordination rather than to a specific receptor of its own.

The purity value is a product-label specification, not an assay result. A batch result can only be asserted from that batch’s certificate.

These names help identify the catalog entry. A descriptive label is not evidence of efficacy, and structural identity still requires appropriate documentation.

Copper complex

Reconstitution: Laboratory procedure: allow the closed vial to reach room temperature, disinfect the septum and slowly transfer the diluent against the inner wall of the vial. Do not shake; gently swirl the vial until fully dissolved. Record the volume, diluent and date in the batch log.

Storage: Sealed vial of lyophilized material: store at −20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles of reconstituted material; aliquot when the experimental design permits.

Personal protective equipment: Handle in a clean work area with a lab coat, nitrile gloves and eye protection. Dispose of vials, tips and sharps according to the laboratory waste procedure.

Six references support this record: three reviews and primary work from 1973, 1980 and 2024. The 2026 systematic review alone used explicit inclusion criteria, following PRISMA and searching PubMed, Embase and Cochrane CENTRAL through March 2026. It retained twenty studies, eighteen preclinical and two randomized (42619529), establishing the balance between models and human evidence.

The most recent primary study combined a mouse silicosis model with RAW264.7 alveolar-macrophage cells, identifying peroxiredoxin 6 as a binding protein in experimental models and measuring lung inflammation, fibrosis and macrophage oxidative-stress markers (38879894). The older studies concern human serum and plasma and a hepatoma cell line (4349963, 6246126). The 2015 review organizes preclinical skin findings involving collagen, dermatan sulfate, chondroitin sulfate and decorin synthesis and metalloproteinase activity relative to inhibitors, while also recording hair-follicle, digestive-tract and bone research (26236730). The 2018 review revisits that literature through gene expression (29986520). Clinical outcomes in the systematic review include dermatological findings after laser procedures and wrinkle-volume and depth measurements (42619529). Sources: PMID 42619529; PMID 38879894; PMID 26236730; PMID 29986520; PMID 4349963; PMID 6246126.

These sources describe endogenous presence and coordination chemistry rather than a time course of exposure. The 1980 in vitro and human-plasma work found the tripeptide complexed with copper and iron and, at physiological pH, associated with cobalt, molybdenum, nickel and zinc but not calcium, potassium or sodium (6246126). This transition-metal selectivity matters because the material reaching culture medium is a chelate rather than free peptide. The 2015 review records detection in human plasma, saliva and urine and declining concentration with age (26236730); the silicosis study also describes it as a natural blood and urine constituent (38879894). Some studies in the systematic review used microneedles or liposomes to alter transdermal passage (42619529). This bibliography does not describe half-life, albumin binding or proteolytic degradation, and outside estimates are not substituted. Sources: PMID 6246126; PMID 26236730; PMID 38879894; PMID 42619529.

The sequence was reported from the human body rather than designed as an analog. Pickart and Thaler described a human-serum tripeptide in 1973, studying normal liver cells and neoplastic liver tissue (4349963). In 1980 they identified it as H-Gly-His-Lys-OH in human plasma, complexed with copper and iron, and compared peptide alone with peptide–metal complexes in a hepatoma line in vitro (6246126). H-…-OH denotes free, nonacetylated and nonamidated ends. This matches the catalog’s declared Gly-His-Lys–copper(II) identity, CAS 89030-95-5 and blue solid, without residue substitutions; literature identity does not itself verify a particular vial. Later reviews reorganize more than four decades of work on the same structure by cellular pathway and then gene expression rather than introducing new chemistry (26236730, 29986520). Sources: PMID 4349963; PMID 6246126; PMID 26236730; PMID 29986520.

AHK-Cu is the only same-class catalog compound. Both are copper(II) complexes of a tripeptide ending in histidine and lysine, differing at the first residue: glycine versus alanine. One residue is enough to prevent automatic transfer of evidence. The six references here concern the glycine tripeptide. Peroxiredoxin-6 binding in a mouse model (38879894) and extracellular-matrix and metalloproteinase findings in preclinical skin models (26236730, 42619529) were not repeated with AHK-Cu in this bibliography. The comparison therefore concerns structure and literature volume, not side-by-side measured activity. GHK-Cu is also a declared ingredient of GLOW and KLOW, retaining its separate bibliography within those blends. Sources: PMID 38879894; PMID 26236730; PMID 42619529.

The 2026 systematic review describes methodological variation and few well-designed trials: twenty studies, only two randomized (42619529). Narrative reviews enumerate preclinical findings across skin, pulmonary connective tissue, bone, liver and gastric mucosa (29986520), with one describing altered expression of at least four thousand human genes (26236730); the PRISMA-filtered review retains only twenty studies. These approaches collect hypotheses and filter study designs differently, so the broader narrative should not be mistaken for a larger rigorous trial base. Peroxiredoxin-6 binding has been studied in one mouse model without replication elsewhere in this bibliography (38879894), and the foundational work used a hepatoma line, not the reviews’ range of tissues (6246126). Sources: PMID 42619529; PMID 29986520; PMID 26236730; PMID 38879894; PMID 6246126.